Clinical Trial Update: Evaluate The Clinical Effectiveness, Safety And Tolerability Of Sildenafil Used In Doses ≥20mg TID For The Treatment Of Pulmonary Arterial Hypertension

View source ↗

Summary

A completed clinical trial evaluating the effectiveness, safety, and tolerability of sildenafil at doses ≥20 mg three times daily for pulmonary arterial hyperte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Pulmonary Arterial Hypertension | Status: COMPLETED | Results posted: 2012-10-31